Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
暂无分享,去创建一个
C. Geisler | M. Wasik | C. Vetter-Kauczok | T. Krejsgaard | A. Woetmann | J. Becker | E. Ralfkiaer | H. Kneitz | Qian Zhang | N. Ødum | P. Lovato | K. W. Eriksen
[1] C. Geisler,et al. Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome , 2008, Leukemia.
[2] C. Paweletz,et al. Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma. , 2008, Cancer research.
[3] G. Courtois,et al. Inhibition of IκB Kinase Subunit 2 in Cutaneous T-Cell Lymphoma Down-Regulates Nuclear Factor-κB Constitutive Activation, Induces Cell Death, and Potentiates the Apoptotic Response to Antineoplastic Chemotherapeutic Agents , 2008, Clinical Cancer Research.
[4] A. Hauschild,et al. Maintenance therapy in cutaneous T-cell lymphoma: who, when, what? , 2007, European journal of cancer.
[5] C. Geisler,et al. Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins. , 2007, Blood.
[6] L. F. Glass,et al. The diagnosis, staging, and treatment options for mycosis fungoides. , 2007, Cancer control : journal of the Moffitt Cancer Center.
[7] J. Becker,et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma , 2006, Leukemia.
[8] M. Wasik,et al. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. , 2006, Blood.
[9] R. Dummer,et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. , 2006, European journal of cancer.
[10] G. Courtois,et al. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. , 2006, Blood.
[11] S. Klinken,et al. Cross-regulation of JAK and Src kinases , 2006, Growth factors.
[12] Nicola Pimpinelli,et al. Defining early mycosis fungoides. , 2005, Journal of the American Academy of Dermatology.
[13] C. Geisler,et al. Increased sensitivity to interferon-α in psoriatic T cells , 2005 .
[14] Nicola Pimpinelli,et al. WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.
[15] E. Bettelli,et al. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] L. Showe,et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. , 2005, The Journal of clinical investigation.
[17] M. Wasik,et al. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3 , 2004, Leukemia.
[18] L. Wilson,et al. The pathogenesis of mycosis fungoides. , 2004, The New England journal of medicine.
[19] S. Dehm,et al. SRC gene expression in human cancer: the role of transcriptional activation. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[20] S. Desiderio,et al. Mimicry of Pre–B Cell Receptor Signaling by Activation of the Tyrosine Kinase Blk , 2003, The Journal of experimental medicine.
[21] G. Gallick,et al. Src family kinases in tumor progression and metastasis , 2003, Cancer and Metastasis Reviews.
[22] E. Glusac. Criterion by criterion, mycosis fungoides. , 2003, The American Journal of dermatopathology.
[23] A. Tarakhovsky,et al. Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development , 2003, Nature Immunology.
[24] L. Ellis,et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis , 2002, Oncogene.
[25] R. Edelson. Cutaneous T Cell Lymphoma , 2001, The Journal of dermatologic surgery and oncology.
[26] S. Alkan,et al. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. , 2000, Human pathology.
[27] T. Mustelin,et al. Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway. , 2000, European cytokine network.
[28] C. Geisler,et al. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells , 1999, Leukemia.
[29] P. Zwollo,et al. The Transcription Factor NF-κB/p50 Interacts with the blkGene during B Cell Activation* , 1998, The Journal of Biological Chemistry.
[30] H. Dintzis,et al. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Halaban,et al. Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk , 1997, Leukemia.
[32] D. Seldin,et al. Analysis of IL-2, IL-4 and their receptors in clonally-related cell lines derived from a patient with a progressive cutaneous T-cell lymphoproliferative disorder. , 1996, Leukemia & lymphoma.
[33] C. B. Pedersen,et al. Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines. , 1995, Cancer genetics and cytogenetics.
[34] M. Campbell,et al. Transcription of the blk Gene in Human B Lymphocytes Is Controlled by Two Promoters (*) , 1995, The Journal of Biological Chemistry.
[35] C. Baldari,et al. p56lck plays a key role in transducing apoptotic signals in T cells , 1995, FEBS letters.
[36] J. Niederhuber,et al. Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk). , 1995, Oncogene.
[37] C. I. Smith,et al. Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk. , 1995, Journal of immunology.
[38] H. Hanafusa,et al. Functional analysis of Csk in signal transduction through the B-cell antigen receptor , 1994, Molecular and cellular biology.
[39] J. Fargnoli,et al. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Desiderio,et al. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein. , 1994, The Journal of biological chemistry.
[41] K. thestrup-pedersen,et al. Cytogenetic findings in cell lines from cutaneous T-cell lymphoma. , 1994, Dermatologic clinics.
[42] S. Malek,et al. SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes. , 1993, The Journal of biological chemistry.
[43] Philippe Soriano,et al. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice , 1993, Cell.
[44] E. Boel,et al. Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides , 1992, In Vitro Cellular & Developmental Biology - Animal.
[45] A. Burkhardt,et al. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Weiss,et al. Association of the human CD3-zeta chain with the alpha beta-T cell receptor/CD3 complex. Clues from a T cell variant with a mutated T cell receptor-alpha chain. , 1990, Journal of immunology.
[47] J. Siegel,et al. A bioassay for the measurement of human interleukin-4. , 1990, Journal of immunological methods.
[48] S. Desiderio,et al. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. , 1990, Science.
[49] B. Thiers. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) , 2008 .
[50] C. Geisler,et al. Increased sensitivity to interferon-alpha in psoriatic T cells. , 2005, The Journal of investigative dermatology.
[51] R. Edelson. Cutaneous T cell lymphoma: the helping hand of dendritic cells. , 2001, Annals of the New York Academy of Sciences.
[52] P. Zwollo,et al. The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation. , 1998, The Journal of biological chemistry.
[53] Sheila M. Thomas,et al. Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.